Literature DB >> 22989522

Analysis of kalirin-7 knockout mice reveals different effects in female mice.

Christopher M Mazzone1, Taylor P Larese, Drew D Kiraly, Betty A Eipper, Richard E Mains.   

Abstract

Estradiol treatment of ovariectomized rodents is known to affect the morphology of dendritic spines and produce behavioral and cognitive effects. Kalirin-7 (Kal7), a postsynaptic density (PSD)-localized Rho-guanine nucleotide exchange factor, is important for dendritic spine formation and stability. Male Kal7 knockout [Kal7(KO)] mice exhibit a number of abnormal behavioral and biochemical phenotypes. Given that chronic 17β-estradiol (E2) replacement of ovariectomized rats enhanced Kal7 expression in the hippocampus and primary hippocampal cultures, we assessed the behavioral and biochemical effects of chronic E2 treatment of ovariectomized female wild-type and Kal7(KO) mice. Both intact and ovariectomized Kal7(KO) female mice exhibited decreased anxiety-like behavior compared with the corresponding wild type in the elevated zero maze and were unaffected by E2 treatment. Chronic E2 decreased locomotor activity in the open field and enhanced performance in a passive-avoidance fear conditioning task, which were both unaffected by genotype. Kal7(KO) female mice engaged in significantly more object exploration, both familiar and novel, than did wild-type females. E2 enhanced the acute locomotor response to cocaine, with no significant effect of genotype. Similar to Kal7(KO) males, Kal7(KO) females had decreased levels of N-methyl-d-aspartate receptor 2B in hippocampal PSD fractions with no effect of E2 treatment. The differing behavioral effects of Kal7 ablation in female and male mice may offer insight into the molecular underpinnings of these differences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22989522      PMCID: PMC3502624          DOI: 10.1124/mol.112.080838

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  58 in total

Review 1.  Structure and function of dendritic spines.

Authors:  Esther A Nimchinsky; Bernardo L Sabatini; Karel Svoboda
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

2.  Estradiol-induced object memory consolidation in middle-aged female mice requires dorsal hippocampal extracellular signal-regulated kinase and phosphatidylinositol 3-kinase activation.

Authors:  Lu Fan; Zaorui Zhao; Patrick T Orr; Cassie H Chambers; Michael C Lewis; Karyn M Frick
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

3.  Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization.

Authors:  R C Pierce; K Bell; P Duffy; P W Kalivas
Journal:  J Neurosci       Date:  1996-02-15       Impact factor: 6.167

4.  Bisphenol-A rapidly enhanced passive avoidance memory and phosphorylation of NMDA receptor subunits in hippocampus of young rats.

Authors:  Xiaohong Xu; Tao Li; Qingqing Luo; Xing Hong; Lingdan Xie; Dong Tian
Journal:  Toxicol Appl Pharmacol       Date:  2011-07-06       Impact factor: 4.219

5.  Chronic nicotine exposure inhibits estrogen-mediated synaptic functions in hippocampus of female rats.

Authors:  Ami P Raval; Justin T Sick; Gabriel J Gonzalez; R Anthony Defazio; Chuanhui Dong; Thomas J Sick
Journal:  Neurosci Lett       Date:  2012-04-12       Impact factor: 3.046

6.  Differential effects of etifoxine on anxiety-like behaviour and convulsions in BALB/cByJ and C57BL/6J mice: any relation to overexpression of central GABAA receptor beta2 subunits?

Authors:  Marc Verleye; Sylvie Dumas; Isabelle Heulard; Nicolas Krafft; Jean-Marie Gillardin
Journal:  Eur Neuropsychopharmacol       Date:  2010-10-12       Impact factor: 4.600

7.  Estradiol potentiation of NR2B-dependent EPSCs is not due to changes in NR2B protein expression or phosphorylation.

Authors:  Melissa A Snyder; Bradley M Cooke; Catherine S Woolley
Journal:  Hippocampus       Date:  2011-04       Impact factor: 3.899

8.  Sex differences in cocaine-induced behavioral responses, pharmacokinetics, and monoamine levels.

Authors:  Eugene D Festa; Scott J Russo; Farhad M Gazi; Tipyamol Niyomchai; Lynne M Kemen; Shen-Nan Lin; Rodger Foltz; Shirzad Jenab; Vanya Quinones-Jenab
Journal:  Neuropharmacology       Date:  2004-04       Impact factor: 5.250

9.  Estradiol-induced enhancement of object memory consolidation involves NMDA receptors and protein kinase A in the dorsal hippocampus of female C57BL/6 mice.

Authors:  Michael C Lewis; Kristin M Kerr; Patrick T Orr; Karyn M Frick
Journal:  Behav Neurosci       Date:  2008-06       Impact factor: 1.912

10.  Kalrn promoter usage and isoform expression respond to chronic cocaine exposure.

Authors:  Richard E Mains; Drew D Kiraly; Jodi E Eipper-Mains; Xin-Ming Ma; Betty A Eipper
Journal:  BMC Neurosci       Date:  2011-02-17       Impact factor: 3.288

View more
  4 in total

1.  Brain Region and Isoform-Specific Phosphorylation Alters Kalirin SH2 Domain Interaction Sites and Calpain Sensitivity.

Authors:  Megan B Miller; Yan Yan; Kazuya Machida; Drew D Kiraly; Aaron D Levy; Yi I Wu; TuKiet T Lam; Thomas Abbott; Anthony J Koleske; Betty A Eipper; Richard E Mains
Journal:  ACS Chem Neurosci       Date:  2017-04-25       Impact factor: 4.418

Review 2.  Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia.

Authors:  Arne W Mould; Noura Al-Juffali; Annette von Delft; Paul E Brennan; Elizabeth M Tunbridge
Journal:  CNS Drugs       Date:  2021-12-20       Impact factor: 5.749

3.  Using Kalirin conditional knockout mice to distinguish its role in dopamine receptor mediated behaviors.

Authors:  Taylor P LaRese; Yan Yan; Betty A Eipper; Richard E Mains
Journal:  BMC Neurosci       Date:  2017-05-23       Impact factor: 3.288

4.  Elimination of Kalrn expression in POMC cells reduces anxiety-like behavior and contextual fear learning.

Authors:  Prashant Mandela; Yan Yan; Taylor LaRese; Betty A Eipper; Richard E Mains
Journal:  Horm Behav       Date:  2014-07-09       Impact factor: 3.587

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.